406 related articles for article (PubMed ID: 33801813)
1. Medically Important Alterations in Transport Function and Trafficking of ABCG2.
Homolya L
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33801813
[TBL] [Abstract][Full Text] [Related]
2. Identification of Two Dysfunctional Variants in the ABCG2 Urate Transporter Associated with Pediatric-Onset of Familial Hyperuricemia and Early-Onset Gout.
Toyoda Y; Pavelcová K; Bohatá J; Ješina P; Kubota Y; Suzuki H; Takada T; Stiburkova B
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33669292
[TBL] [Abstract][Full Text] [Related]
3. Cellular Processing of the ABCG2 Transporter-Potential Effects on Gout and Drug Metabolism.
Mózner O; Bartos Z; Zámbó B; Homolya L; Hegedűs T; Sarkadi B
Cells; 2019 Oct; 8(10):. PubMed ID: 31597297
[TBL] [Abstract][Full Text] [Related]
4. Functional Characterization of Clinically-Relevant Rare Variants in
Toyoda Y; Mančíková A; Krylov V; Morimoto K; Pavelcová K; Bohatá J; Pavelka K; Pavlíková M; Suzuki H; Matsuo H; Takada T; Stiburkova B
Cells; 2019 Apr; 8(4):. PubMed ID: 31003562
[TBL] [Abstract][Full Text] [Related]
5. The Role of ABCG2 in the Pathogenesis of Primary Hyperuricemia and Gout-An Update.
Eckenstaler R; Benndorf RA
Int J Mol Sci; 2021 Jun; 22(13):. PubMed ID: 34206432
[TBL] [Abstract][Full Text] [Related]
6. ABCG2 as a therapeutic target candidate for gout.
Fujita K; Ichida K
Expert Opin Ther Targets; 2018 Feb; 22(2):123-129. PubMed ID: 29264928
[TBL] [Abstract][Full Text] [Related]
7. The impact of dysfunctional variants of ABCG2 on hyperuricemia and gout in pediatric-onset patients.
Stiburkova B; Pavelcova K; Pavlikova M; Ješina P; Pavelka K
Arthritis Res Ther; 2019 Mar; 21(1):77. PubMed ID: 30894219
[TBL] [Abstract][Full Text] [Related]
8. Genetic polymorphisms and decreased protein expression of ABCG2 urate transporters are associated with susceptibility to gout, disease severity and renal-overload hyperuricemia.
Pálinkás M; Szabó E; Kulin A; Mózner O; Rásonyi R; Juhász P; Nagy K; Várady G; Vörös D; Zámbó B; Sarkadi B; Poór G
Clin Exp Med; 2023 Aug; 23(4):1277-1284. PubMed ID: 35939175
[TBL] [Abstract][Full Text] [Related]
9. The ABCG2 Q141K hyperuricemia and gout associated variant illuminates the physiology of human urate excretion.
Hoque KM; Dixon EE; Lewis RM; Allan J; Gamble GD; Phipps-Green AJ; Halperin Kuhns VL; Horne AM; Stamp LK; Merriman TR; Dalbeth N; Woodward OM
Nat Commun; 2020 Jun; 11(1):2767. PubMed ID: 32488095
[TBL] [Abstract][Full Text] [Related]
10. Pleiotropic effect of the ABCG2 gene in gout: involvement in serum urate levels and progression from hyperuricemia to gout.
Wrigley R; Phipps-Green AJ; Topless RK; Major TJ; Cadzow M; Riches P; Tausche AK; Janssen M; Joosten LAB; Jansen TL; So A; Harré Hindmarsh J; Stamp LK; Dalbeth N; Merriman TR
Arthritis Res Ther; 2020 Mar; 22(1):45. PubMed ID: 32164793
[TBL] [Abstract][Full Text] [Related]
11. Clinically relevant mutations in the ABCG2 transporter uncovered by genetic analysis linked to erythrocyte membrane protein expression.
Zámbó B; Bartos Z; Mózner O; Szabó E; Várady G; Poór G; Pálinkás M; Andrikovics H; Hegedűs T; Homolya L; Sarkadi B
Sci Rep; 2018 May; 8(1):7487. PubMed ID: 29749379
[TBL] [Abstract][Full Text] [Related]
12. Identification of a urate transporter, ABCG2, with a common functional polymorphism causing gout.
Woodward OM; Köttgen A; Coresh J; Boerwinkle E; Guggino WB; Köttgen M
Proc Natl Acad Sci U S A; 2009 Jun; 106(25):10338-42. PubMed ID: 19506252
[TBL] [Abstract][Full Text] [Related]
13. Trans-ancestral dissection of urate- and gout-associated major loci SLC2A9 and ABCG2 reveals primate-specific regulatory effects.
Takei R; Cadzow M; Markie D; Bixley M; Phipps-Green A; Major TJ; Li C; Choi HK; Li Z; Hu H; ; Guo H; He M; Shi Y; Stamp LK; Dalbeth N; Merriman TR; Wei WH
J Hum Genet; 2021 Feb; 66(2):161-169. PubMed ID: 32778763
[TBL] [Abstract][Full Text] [Related]
14. The ABCG2/BCRP transporter and its variants - from structure to pathology.
Sarkadi B; Homolya L; Hegedűs T
FEBS Lett; 2020 Dec; 594(23):4012-4034. PubMed ID: 33015850
[TBL] [Abstract][Full Text] [Related]
15. Epistatic interaction between PKD2 and ABCG2 influences the pathogenesis of hyperuricemia and gout.
Dong Z; Zhou J; Jiang S; Li Y; Zhao D; Yang C; Ma Y; He H; Ji H; Jin L; Zou H; Wang J
Hereditas; 2020 Jan; 157(1):2. PubMed ID: 32000861
[TBL] [Abstract][Full Text] [Related]
16. The prevalence of the gout-associated polymorphism rs2231142 G>T in ABCG2 in a pregnant female Filipino cohort.
Roman Y; Tiirikainen M; Prom-Wormley E
Clin Rheumatol; 2020 Aug; 39(8):2387-2392. PubMed ID: 32107664
[TBL] [Abstract][Full Text] [Related]
17. Identification of ABCG2 dysfunction as a major factor contributing to gout.
Matsuo H; Takada T; Ichida K; Nakamura T; Nakayama A; Takada Y; Okada C; Sakurai Y; Hosoya T; Kanai Y; Suzuki H; Shinomiya N
Nucleosides Nucleotides Nucleic Acids; 2011 Dec; 30(12):1098-104. PubMed ID: 22132963
[TBL] [Abstract][Full Text] [Related]
18. Gout-causing Q141K mutation in ABCG2 leads to instability of the nucleotide-binding domain and can be corrected with small molecules.
Woodward OM; Tukaye DN; Cui J; Greenwell P; Constantoulakis LM; Parker BS; Rao A; Köttgen M; Maloney PC; Guggino WB
Proc Natl Acad Sci U S A; 2013 Mar; 110(13):5223-8. PubMed ID: 23493553
[TBL] [Abstract][Full Text] [Related]
19. [ROLE OF SLC2A9 AND ABCG2 GENE POLYMORPHISMS IN ORIGIN OF HYPERURICEMIA AND GOUT].
Fadieieva A; Prystupa L; Pogorelova O; Kirichenko N; Dudchenko I
Georgian Med News; 2016 Mar; (252):79-83. PubMed ID: 27119840
[TBL] [Abstract][Full Text] [Related]
20. Functional non-synonymous variants of ABCG2 and gout risk.
Stiburkova B; Pavelcova K; Zavada J; Petru L; Simek P; Cepek P; Pavlikova M; Matsuo H; Merriman TR; Pavelka K
Rheumatology (Oxford); 2017 Nov; 56(11):1982-1992. PubMed ID: 28968913
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]